Your browser doesn't support javascript.
loading
Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome.
Earhart, A P; Holliday, Z M; Hofmann, H V; Schrum, A G.
Afiliação
  • Earhart AP; Molecular Pathogenesis & Therapeutics Program, University of Missouri Graduate School, Columbia, MO, USA.
  • Holliday ZM; Pulmonary Disease, Critical Care Medicine, School of Medicine, University of Missouri, Columbia, MO, USA.
  • Hofmann HV; Pulmonary Disease, Critical Care Medicine, School of Medicine, University of Missouri, Columbia, MO, USA.
  • Schrum AG; Molecular Microbiology & Immunology, University of Missouri, Columbia, MO, USA.
New Microbes New Infect ; 35: 100689, 2020 May.
Article em En | MEDLINE | ID: mdl-32355564
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: New Microbes New Infect Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: New Microbes New Infect Ano de publicação: 2020 Tipo de documento: Article